Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain)

BMC Cancer

Volumn 9, Issue , 2009, Pages 326-

  Rue, Montserrat ^a,b   Vilaprinyo, Ester ^c   Lee, Sandra ^d   Martinez Alonso, Montserrat ^a   Carles, Misericor dia ^e   Marcos Gragera, Rafael ^f,g   Pla, Roger ^h   Espinas, Josep Alfons ^g  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c Hospital of Tortosa   (Spain)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^f DEPARTMENT OF HEALTH   (Spain)

^g Catalan Cancer Plan   (Spain)

^h INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; MAMMOGRAPHY; MATHEMATICAL MODEL; PERIODICITY; PROBABILITY; RISK REDUCTION; SENSITIVITY ANALYSIS; SPAIN; STOCHASTIC MODEL; SURVIVAL TIME;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; SPAIN;

EID: 70449395230     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-326     Document Type: Article

References (34)

1. Olsen O, Gotzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2001, (4):CD001877.
2. de Koning HJ. Mammographic screening: evidence from randomised controlled trials. Ann Oncol 2003, 14:1185-1189. 10.1093/annonc/mdg319, 12881373.
3. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, . Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353:1784-1792. 10.1056/NEJMoa050518, 16251534.
4. Feuer E, Plevritis SK, Berry DA, Cronin KA, , . eds, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators The impact of mammography and adjuvant therapy on US breast cancer mortality (1975-2000): collective results from the Cancer Intervention and Surveillance modeling network. J Natl Cancer Inst Monogr 2006, (36):1-126.
5. Lee SJ, Zelen M. Mortality Modeling of Early Detection Programs. Biometrics 2008, 64:386-395. 10.1111/j.1541-0420.2007.00893.x, 17725809.
6. Zelen M, Lee SJ. Models and the early detection of disease: methodological considerations. Cancer Treat Res 2002, 113:1-18.
7. Lee S, Zelen M. A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr 2006, (36):79-86.
8. Lee SJ, Zelen M. Modelling the early detection of breast cancer. Ann Oncol 2003, 14:1199-1202. 10.1093/annonc/mdg323, 12881377.
9. Lee S, Huang H, Zelen M. Early detection of disease and scheduling of screening examinations. Stat Methods Med Res 2004, 13:443-456. 10.1191/0962280204sm377ra, 15587433.
10. Lee S, Zelen M. Scheduling periodic examinations for the early detection of disease: applications to breast cancer. J Am Stat Assoc 1998, (93):1271-1281.
11. Beemsterboer PMM, Warmerdam PG, Boer R, Borras JM, Moreno V, Viladiu P, de Konning HJ. Screening for breast cancer in Catalonia. Which policy is to be preferred?. Eur J Public Health 1998, 8:241-246.
12. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983, 39:311-324. 10.2307/2531004, 6626659.
13. International Agency for Research on Cancer CANCER Mondial. 2007, , http://www-dep.iarc.fr
14. Instituto Nacional de Estadística Population data. 2007, , http://www.ine.es
15. McCullagh P, Nelder JA. Generalized linear models 1983, Monographs on statistics and applied probability, London-New York: Chapman and Hall.
16. Rosenberg M. Competing risks to breast cancer mortality. J Natl Cancer Inst Monogr 2006, 36:15-9.
17. Generalitat de Catalunya Departament de Sanitat i Seguretat Social Direcció General de Recursos Sanitaris Anàlisi de la mortalitat a Catalunya 1983-2006. , http://www.gencat.net/salut/
18. Institut d'Estadística de Catalunya Padró municipal d'habitants. 2007, , http://www.idescat.net
19. Vilaprinyo E, Gispert R, Martinez-Alonso M, Carles M, Pla R, Espinas JA, Rue M. Competing Risks to Breast Cancer Mortality in Catalonia. BMC Cancer 2008, 8:331. doi:10.1186/1471-2407-8-331., 10.1186/1471-2407-8-331, 2636833, 19014473.
20. Vilaprinyo E, Rue M, Marcos-Gragera R, Martinez-Alonso M. Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data. BMC Cancer 2009, 9:98. doi:10.1186/1471-2407-9-98., 10.1186/1471-2407-9-98, 2679763, 19331670.
21. Rue M, Carles M, Vilaprinyo E, Martinez-Alonso M, Espinas JA, Pla R, Brugulat P. Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain). BMC Cancer 2008, 8:336. doi:10.1186/1471-2407-8-336., 10.1186/1471-2407-8-336, 2613154, 19014679.
22. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 2006, 98:774-782.
23. Woo PP, Kim JJ, Leung GM. What is the most cost-effective population-based cancer screening program for Chinese women?. J Clin Oncol 2007, 25:617-624. 10.1200/JCO.2006.06.0210, 17308266.
24. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006, (4):CD001877.
25. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003, 361:1405-1410. 10.1016/S0140-6736(03)13143-1, 12727392.
26. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, Ljungquist U, Lundstrom B, Manson JC, Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985, 1:829-832. 10.1016/S0140-6736(85)92204-4, 2858707.
27. Swedish Organised Service Screening Evaluation Group Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006, 15:45-51. 10.1158/1055-9965.EPI-05-0349, 16434585.
28. Swedish Organised Service Screening Evaluation Group Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 2006, 15:52-56. 10.1158/1055-9965.EPI-05-0953, 16434586.
29. Anderson WF, Jatoi I, Devesa SS. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat 2006, 99:333-340. 10.1007/s10549-006-9214-z, 16703451.
30. Holford TR, Cronin KA, Mariotto AB, Feuer EJ. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr 2006, (36):19-25.
31. Blanchard K, Colbert JA, Kopans DB, Moore R, Halpern EF, Hughes KS, Smith BL, Tanabe KK, Michaelson JS. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use. Radiology 2006, 240:335-342. 10.1148/radiol.2402050107, 16864665.
32. Christiansen CL, Wang F, Barton MB, Kreuter W, Elmore JG, Gelfand AE, Fletcher SW. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst 2000, 92:1657-1666. 10.1093/jnci/92.20.1657, 11036111.
33. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998, 338:1089-1096. 10.1056/NEJM199804163381601, 9545356.
34. Castells X, Molins E, Macia F. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme. J Epidemiol Community Health 2006, 60:316-321. 10.1136/jech.2005.042119, 2593411, 16537348.